Urolithin A for Rock Climbers: Forearm Endurance, Recovery & the Mitochondrial Story

Climbing is rarely lost on a single hard move. It is lost a few moves later, when the forearms stop answering, the grip slowly opens, and the next hold feels impossible. That slow fade is a question about muscular endurance and how quickly the forearm recovers between efforts — which makes it, at its root, a question about mitochondria. Here is an honest, evidence-first look at where urolithin A fits for climbers, and where it does not.

Climbing is a mitochondrial problem before it is a strength problem

Most climbers assume they fail because they are not strong enough. Occasionally that is true. But on all but the most powerful boulder problems, the limiting factor is usually endurance in the finger flexors — the deep forearm muscles that curl the fingers around a hold. These muscles contract hard and often, and between moves they need to clear metabolic by-products and re-oxygenate before the next pull. The faster a forearm can restore oxygen and keep its energy supply flowing, the longer a climber can stay on the wall before the dreaded “pump” forces a fall or a rest.

Interestingly, the capacity that predicts this is local and aerobic. A study of sport climbers using near-infrared spectroscopy found that a forearm oxidative-capacity index — essentially how quickly the flexor muscle re-saturated with oxygen after a bout of effort — was associated with a higher self-reported red-point grade, even after accounting for age, sex, body mass and experience. An earlier look at raw blood flow to the arm had not predicted performance, which pointed researchers toward muscle-level factors: how well the tissue itself extracts and uses oxygen. This was an observational association in a small group, not proof of cause, and the authors were careful to say it does not explain all the variance in climbing ability. But it reframes the goal usefully: train and support the forearm's ability to produce energy aerobically and recover between efforts, not just its peak crushing force.

Aerobic energy production is the job of the mitochondria — the structures inside each muscle cell that turn oxygen and fuel into usable energy (ATP). This is exactly the territory urolithin A is studied in.

What urolithin A is, and what it actually does in muscle

Urolithin A is a postbiotic: your gut bacteria make it from ellagitannins, the compounds found in pomegranates, walnuts and certain berries. Most people cannot produce meaningful amounts, because the ability depends on having the right gut microbes — which is why a standardized supplement exists at all. For more background on the molecule itself, see our complete urolithin A guide.

Its best-characterized action is supporting mitophagy — the cell's housekeeping process for recycling worn-out, underperforming mitochondria so that fresher, more efficient ones can take their place. The foundational work here (Ryu and colleagues, 2016) was preclinical: in roundworms and rodents, urolithin A induced mitophagy, improved measures of muscle function and extended lifespan in the worm model. That is animal and cell research, not human proof, and it should be read as mechanism rather than a promise. The first-in-human trial (Andreux and colleagues, 2019) then showed that oral urolithin A was safe and well tolerated at doses up to 1,000 mg per day in healthy older adults, and that it shifted mitochondrial and cellular-health gene-expression signatures in the direction the preclinical work predicted.

The human evidence on endurance and strength

Several human trials have now looked at whether that mechanism translates into something you can measure in a muscle:

In a randomized, placebo-controlled trial in older adults (Liu, D'Amico and colleagues, 2022, published in JAMA Network Open), roughly four months of urolithin A was associated with improvements in muscle endurance — the number of contractions a muscle could sustain before fatigue — alongside favorable changes in plasma biomarkers linked to mitochondrial health. A separate randomized trial in middle-aged adults (Singh and colleagues, 2022, in Cell Reports Medicine) tested 500 mg and 1,000 mg daily over four months and reported improvements in muscle strength and aspects of exercise performance. More recently, an eight-week randomized controlled trial in resistance-trained men (Journal of the International Society of Sports Nutrition, 2024) examined endurance and recovery-related markers in people who already train hard.

Taken together, the pattern is consistent and encouraging: urolithin A tends to support muscular endurance and the cellular machinery behind it, rather than acting as an acute, pre-send jolt. The honest caveat is equally important — none of these trials studied climbers, finger flexors or grip-specific endurance. We are reasoning from general skeletal-muscle findings to a sport that leans heavily on forearm aerobic capacity. That is a reasonable bridge, but it is an inference, not a demonstrated climbing result.

Recovery between sessions and on long projecting days

Climbers do not just care about staying on the wall longer; they care about how their forearms feel two days later, and whether they can project the same crux three sessions a week without the elbows and fingers staging a revolt. Because mitochondrial quality underlies how efficiently muscle produces energy and manages the stress of repeated loading, the same endurance-supporting mechanism is plausibly relevant to between-session recovery. The human trials emphasized endurance and strength outcomes rather than soreness per se, so treat recovery benefits as a reasonable extension of the mechanism and the resistance-trained data — genuinely promising, not guaranteed. You can read more in our pages on urolithin A for recovery and urolithin A for muscle.

How a climber can actually use it

Dose and timing

The clinically studied range is 500–1,000 mg per day, taken consistently. Because the effect is cumulative rather than acute, timing around a session is not critical — there is no need to dose right before you tie in. Pick a time you will not forget, such as with breakfast, and keep it daily.

Give it a real trial

The trials above ran for roughly two to four months. If you are going to evaluate whether urolithin A does anything for your climbing, commit to a full training block and judge it the way you would judge a new endurance protocol — over a season, not a single session.

Pair it with the training that actually builds forearm endurance

No supplement replaces the specific stimulus. Repeaters, aerobic forearm capacity work (such as low-intensity, high-volume hangboard or ARC training), and good sleep and protein intake are what build the oxidative capacity the climbing study pointed to. Urolithin A is a support to that work, not a substitute for it — see urolithin A for athletes for how to fit it into a training routine, and compare formats in our guide to the best urolithin A gummies.

Honest limits and safety

Urolithin A is studied as a structure/function supplement that supports mitochondrial and muscle health. It is not a treatment for climbing injuries. Finger-pulley strains, flexor-tendon issues, tennis or golfer's elbow, and shoulder impingement are injuries, not energy problems — and no supplement fixes them. If you have persistent finger, elbow or shoulder pain, see a sports-medicine clinician or physiotherapist rather than reaching for a gummy. In the human trials to date, urolithin A has been well tolerated at up to 1,000 mg per day, but if you are pregnant, breastfeeding, or taking medication, talk to your doctor before starting any new supplement.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.